The most common side effects reported to date have been malnourishment, due to a dramatic reduction in calorie intake, and significant gastrointestinal symptoms
The research also revealed that there is "a drive to prescribe, rather than making sure the patient is going to be safe in taking these medications and that the medication is going to be appropriate for them," Ramachandran said.
It is currently only available within clinical trial settings and is being evaluated for the treatment of obesity and type 2 diabetes
Hormonal conditions such as hypothyroidism or polycystic ovary syndrome (PCOS) can also affect the rate of weight loss and should be assessed and managed alongside any pharmacological treatment
Results were given in logarithm of the minimum angle of resolution (logMAR)
Here are some others: Pancreatitis Pancreatitis is the inflammation or swelling of the pancreas and can, on rare occasions, potentially be triggered by GLP-1 drugs like Ozempic